The global burden of rheumatoid arthritis: Estimates from the Global Burden of Disease 2010 study

Annals of the Rheumatic Diseases

Volumn 73, Issue 7, 2014, Pages 1316-1322

  Cross, Marita ^a   Smith, Emma ^a   Hoy, Damian ^b   Carmona, Loreto ^c   Wolfe, Frederick ^d   Vos, Theo ^b,e   Williams, Benjamin ^f   Gabriel, Sherine ^g   Lassere, Marissa ^h,i   Johns, Nicole ^e   Buchbinder, Rachelle ^j,k   Woolf, Anthony ^l   March, Lyn ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Instituto de Salud Musculoesquelética InMusc Calle Hilarión Eslava   (Spain)

^d NATIONAL DATA BANK FOR RHEUMATIC DISEASES   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF NEW SOUTH WALES   (Australia)

ⁱ ST GEORGE HOSPITAL   (Australia)

^j CABRINI INSTITUTE   (Australia)

^k MONASH UNIVERSITY   (Australia)

^l ROYAL CORNWALL HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; DISABILITY ADJUSTED LIFE YEAR; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; MALE; MORTALITY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SEX DIFFERENCE; SYSTEMATIC REVIEW; VERY ELDERLY; YEARS OF LIFE LIVED WITH DISABILITY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; WORLD HEALTH; YOUNG ADULT;

EID: 84902261143     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204627     Document Type: Article

References (31)

1. World Health Organisation. The global burden of disease: 2004 update. Geneva: World Health Organisation, 2008.
2. Lopez A, Mathers C, Ezzati M, et al. Global Burden of Disease and risk factors. New York, NY: World Bank, 2006.
3. Murray C, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013;380:2197-223.
4. Vos T, Flaxman A, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163-96.
5. Smith E, Hoy D, Cross M, et al. The global burden of other musculoskeletal disorders: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. In press.
6. Hoy D, March L, Brooks P, et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. In press.
7. Hoy D, March L, Woolf A, et al. The global burden of neck pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. In press.
8. Hoy D, Smith E, Cross M, et al. The global burden of musculoskeletal conditions for 2010: An overview of methods. Ann Rheum Dis. In press.
9. Sanchez-Riera L, Carnahan E, Vos T, et al. Global Burden Attributable to Low Bone Mineral Density. Ann Rheum Dis. In press.
10. Smith E, Hoy D, Cross M, et al. The global burden of gout: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. In press.
11. Driscoll T, Jacklyn G, Orchard J, et al. The global burden of occupationally-related low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. In press.
12. Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. In press.
13. Murray C, Ezzati M, Flaxman A, et al. The Global Burden of Disease Study 2010: design, definitions and metrics. Lancet 2012;380:2063-6.
14. Arnett F, Edworthy S, Bloch D, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
15. Aletaha D, Neogi T, Silman A, et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69: 1580-8.
16. Hoy D, Brooks P, Woolf A, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol 2012;65:934-9.
17. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013;380:2095-128.
18. Willers J, Hahn A. Cardiovascular risk in patients with rheumatoid arthritis: Assessment of several traditional risk parameters and a German risk score model. Rheumatol Int 2012;32:3741-9.
19. Murray C, Ezzati M, Flaxman A, et al. GBD 2010: A multi-investigator collaboration for global comparative descriptive epidemiology. Lancet 2012;380:2055-8.
20. Salomon J, Vos T, Hogan D, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012;380:2129-43.
21. Sany J, Bourgeois P, Saraux A, et al. Characteristics of patients with rheumatoid arthritis in France: A study of 1109 patients managed by hospital based rheumatologists. Ann Rheum Dis 2004;63:1235-40. (Pubitemid 39273500)
22. Baddoura R, Haddad S, Awada H, et al. Severity of rheumatoid arthritis: The SEVERA study. Clin Rheumatol 2006;25:700-4. (Pubitemid 44111314)
23. Carmona L, González-Álvaro I, Balsa A, et al. Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis 2003;62:897-901.
24. Jantti J, Kaarela K, Belt E, et al. Incidence of severe outcome in rheumatoid arthritis during 20 years. J Rheumatol 2002;29:688-92. (Pubitemid 34303861)
25. Calvo-Alen J, Corrales A, Sanchez-Andrada S, et al. Functional outcome and subset identification in RA patients from meridional Europe: Analysis of a Spanish cohort. Clin Rheumatol 2003;22:77-83. (Pubitemid 36748852)
26. Wolfe F, Michaud K, Strand V. Expanding the definition of clinical differences: From minimally clinically important differences to really important differences. Analysis in 8931 patients with rheumatoid arthritis. J Rheumatol 2005;32:583-9. (Pubitemid 40524688)
27. Marra C, Woolcott J, Kopec J, et al. A comparison of generic, indirect utility measures (th HU12, HU13, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQol and the HAQ) in rheumatoid arthritis. Soc Sci Med 2005;60:1571-82. (Pubitemid 40126441)
28. Goodson N, Wiles N, Lumt M, et al. Mortality in early inflammatory polyarthritis. Arthritis Rheum 2002;46:2010-19.
29. EpiGear International Pty Ltd. MetaXL Version 1.0. Brisbane, Australia, 2011. http://www.epigear.com/index-files/MetaXL%20User%20Guide.pdf.
30. Murray CJL, Lopez, AD, eds. The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Global Burden of disease and Injury Series, Vol. 1. Cambridge: Harvard University Press; 1996.
31. Ahmadi B, Boschi-Pinto C, Lopez A, et al. Age standardization of rates: A new WHO standard. Geneva: World Health Organisation, 2001.